Future of T1D Research

JDRF is creating a future without type 1 diabetes (T1D) by funding and advocating for breakthrough scientific research. One of our strategies is to help promising scientists establish careers in the field of T1D research. The investigators featured here form the newest group to receive early-career funding from JDRF. Meet the future of T1D research.

Career Development Awards

These awards are designed to attract exceptionally promising investigators early in their faculty careers. In the five-year term of the award, grantees will have the opportunity to position themselves at the leading edge of T1D research, on a subject directly related to JDRF mission goals and research priorities.

  • Danny Chou, Ph.D.

    Development of ultrafast-acting insulin for applications in artificial pancreas

    University of Utah

  • Everett Meyer, M.D., Ph.D.

    Developing chimeric antigen receptor T regulatory cells for islet allograft tolerance

    Stanford University

    Link to blog post

  • Jeffrey Millman, Ph.D.

    Improved generation of stem cell-derived beta cells

    Washington University

    Link to blog post

  • Andrew Sutherland, Ph.D.

    Type 17 immunity in T1D

    St. Vincent's Institute of Medical Research

    Link to blog post

Early Career Patient-Oriented Diabetes Research Awards

These awards are intended for clinical researchers at a relatively early stage of their independent career. Recipients must have an M.D. or M.D.-Ph.D., hold an appointment or joint appointment in a subspecialty of clinical medicine in a clinical department and conduct clinical research.

  • Brigitte Frohnert, M.D., Ph.D.

    Gene-lipidome interaction in late-onset islet autoimmunity

    University of Colorado

    Link to blog post

Advanced Postdoctoral Fellowships

These awards are designed to attract qualified and promising health scientists to receive full-time research training, assisting these promising individuals in the transition from a fellowship to an independent position. This three-year award term has an optional one-year transition award, to serve as a bridge between the fellowship and an independent faculty appointment.

  • Eleni Beli, Ph.D.

    Novel insights on the link between diabetic retinopathy and the splenic clock

    Indiana University

  • Erine Budi, Ph.D.

    Integration of increased TGF-beta signaling in the cellular response to insulin or high glucose

    University of California, San Francisco

  • Heather Denroche, Ph.D.

    Targeting islet amyloid for diabetes prevention and improved beta cell replacement therapy

    The University of British Columbia

  • Chiara Fabris, Ph.D.

    CGM-based insulin sensitivity estimation to improve insulin dosing in T1D

    The University of Virginia

  • Nina Funa, Ph.D.

    Identification of signaling pathways controlling expansion of human pancreatic progenitor cells

    The Danish Stem Cell Center, The University of Copenhagen

    Link to blog post

  • Manoj Gupta, Ph.D.

    Modeling T1D and its associated complications using human induced pluripotent stem cells

    Joslin Diabetes Center

  • Zeno Lavagnino, Ph.D.

    Quantitative multiscale imaging to investigate the regulation of glucagon secretion in pancreatic islet

    Washington University

  • Anna Long, Ph.D.

    Adult onset T1D: Slow progressors or late starters?

    University of Bristol

  • Adriana Migliorini, Ph.D.

    Macrophages-endocrine cross talk during human pancreas development

    McEwen Centre for Regenerative Medicine, Toronto General Research Institute, University Health Network

  • Candace Reno, Ph.D.

    Preventing severe hypoglycemia-induced cardiac arrhythmias

    University of Utah

    Link to blog post

  • Xuewei Wang, Ph.D.

    Nitric oxide-releasing cannula integrated with glucose electrode for long-term single-port glycemic control

    The University of Michigan

    Link to blog post

Postdoctoral Fellowships

Postdoctoral fellowships are designed to attract qualified, promising scientists in the T1D research field. These recipients are to work with a sponsor who can provide a training environment conducive to beginning a professional career in T1D-related research.

  • Satoru Akazawa, M.D., Ph.D.

    Defining a new role for granzyme A in maintaining immune tolerance

    St. Vincent's Institute of Medical Research

  • Jenny Aurielle Babon, Ph.D.

    Autoreactive CD8 T cell infiltrates from the islets of human subjects with T1D

    University of Massachusetts Medical School

  • Romina Bevacqua, Ph.D.

    Innovating genetic studies to promote human islet regeneration

    Stanford University

  • Chandrabali Bhattacharya, Ph.D.

    Novel glucose-responsive tripeptides for smart insulin

    Massachusetts Institute of Technology

  • Robert Bone, Ph.D.

    ER calcium dyshomeostasis in the pathogenesis of T1D

    Indiana University

  • Mijke Buitinga, Ph.D.

    Post-translational modification of beta-cell proteins: Towards a better understanding and detection of T1D

    KU Leuven, Belgium

  • Diao Chen, Ph.D.

    Development of glucose-responsive insulin derivatives

    University of Utah

  • Yi-Chun Chen, Ph.D.

    Alternatively processed forms of islet amyloid polypeptide as predictive biomarkers for T1D

    The University of British Columbia

  • Yen-Shan Chen, Ph.D.

    Design of a glucose-responsive insulin based on a conformational switch

    Case Western Reserve University

    Link to blog post

  • Devy Deliyanti, Ph.D.

    Boosting the immune system to treat diabetic retinopathy

    Monash University

  • Joseph Feduska, Ph.D.

    Oxidative post-translational modification of T1D autoantigens

    University of Alabama at Birmingham

  • Laura Jacobsen, M.D.

    Characterization of T cell autoreactivity in T1D

    University of Florida

  • Piotr Kowalski, Ph.D.

    Engineering mRNA nanocarriers to rescue pancreatic beta cells in T1D

    Massachusetts Institute of Technology

    Link to blog post

  • Purushothaman Kuppan, Ph.D.

    Novel functionalized retrievable scaffolds for islet transplantation

    The University of Alberta

  • Yunxian Liu, Ph.D.

    Systematic identification and validation of causal variants and genes targets associated with T1D

    The University of Virginia

  • Wentong Long, Ph.D.

    Bioengineering adipocytes for the regulated release of bioactive insulin

    The University of Alberta

  • Silvia Minardi, M.Sc., Ph.D.

    Multifunctional bio-inspired nanodelivery systems for T1D

    Northwestern University

  • Tobias Neef, Ph.D.

    Biodegradable PLG nanoparticles for tolerance induction in T1D

    Northwestern University

  • Kim-Vy Nguyen-Ngoc, Ph.D.

    Establishing vascularized human pancreatic islets from hESCs

    University of California, San Diego

  • Vishwendra Patel, Ph.D.

    The role of perifornical hypothalamic orexin-glucose inhibited neurons in hypoglycemia awareness

    Rutgers, The State University of New Jersey

  • Kacey Prentice, Ph.D.

    Targeting lipid chaperone adipocyte protein 2 (aP2) for the prevention of T1D

    Harvard University

  • Ronan Russell, Ph.D.

    Investigating the role of MAFA and MAFB in human beta cell specification and maturation using hESCs as a model

    University of California, San Francisco

  • Shugo Sasaki, M.D., Ph.D.

    Protecting insulin-producing beta cell transplants from death and dysfunction, funded by MilliporeSigma

    The University of British Columbia

  • Elad Sintov, Ph.D.

    Genetic screening for immune-tolerance inducers in stem cell-derived beta cells for cell replacement therapy of T1D, funded by MilliporeSigma

    Harvard University

    Link to blog post

  • Alexandra Smink, Ph.D.

    Towards efficacious oxygen exchanging vasculature in a retrievable PDCCL scaffolds for islet transplantation

    University Medical Center Groningen

  • Subhash Tripathi, Ph.D.

    Cell specific epigenetic landscape in children with T1D

    University of Turku, Finland

  • Verena van der Heide, M.D.

    Mapping the histopathological landscape of the pre-/diabetic human pancreas

    Icahn School of Medicine at Mount Sinai

  • Saurabh Vig, Ph.D.

    Role of surface-expressed glucose-regulated protein 78 in beta cells and their cross-talk with the immune system

    KU Leuven

  • Jessica Weaver, Ph.D.

    Localized immunomodulation to induce tolerance in an extrahepatic encapsulated islet graft

    Georgia Institute of Technology

    Link to blog post

  • Xiaochun Xiong, Ph.D.

    Development of an ultrafast-acting insulin

    University of Utah

  • Ebrahim Zadeh, Ph.D.

    Targeted delivery of adiponectin receptor agonists for promoting beta cell regeneration and survival

    UT Southwestern Medical Center

Psychology Fellowships

These awards are designed to increase the capacity in diabetes clinical psychology and diabetes psychology research. It is a combination of clinical diabetes care and diabetes research, and each recipient should have a career interest in diabetes-specialized psychology.

  • Lindsay Anderson, M.A.

    Ann and Robert H. Lurie Children’s Hospital of Chicago

  • Samantha Barry, Ph.D.

    University of Massachusetts Medical School

  • Sarah Westen, Ph.D.

    Sleep, adherence and glycemic control in adolescents with T1D

    University of Florida

JDRF-ISPAD Fellowships

These awards are designed for International Society for Pediatric and Adolescent Diabetes (ISPAD) members below age 40 (or 45 for the Allan Drash Clinical Fellowship), who wish to pursue a career in diabetes related research. It is designed to cover expenses to an ISPAD member’s Centre of Excellence.

  • Naina Bhat, M.D.

    Allan Drash Clinical Fellowship

    St John’s Medical College and Hospital, Bangalore, India

    Link to blog post

  • Petter Bjornstadt, M.D.

    Diabetic Kidney Alarm study: Tubulopathy in new onset diabetic ketoacidosis

    University of Colorado School of Medicine, Colorado, US

    Link to blog post

  • Mohammad Hosny, M.D.

    Allan Drash Clinical Fellowship

    Mansoura University Children’s Hospital, Mansoura, Egypt

    Link to blog post

  • Wafaa Laymoun, M.D., Ph.D.

    Allan Drash Clinical Fellowship

    Mansoura University Children’s Hospital, Mansoura, Egypt

    Link to blog post

  • Beata Malachowska, M.D., Ph.D.

    Role of lysophosphatidic acid, and elevated serum biomarker, in pathogenesis of HNF1B mediated MODY

    Medical University of Lodz, Lodz, Poland

    Link to blog post

  • Joshua Ngwang Menang, R.N.

    Allan Drash Clinical Fellowship

    Cameroon Laboratory & Medicine Foundation Health Center, Tiko, Cameroon

    Link to blog post

  • Feny Patel, M.D.

    Allan Drash Clinical Fellowship

    Clinic Ahmedabad, Gujarat, India

    Link to blog post

  • Marie Beatrice Saade, M.D.

    Efficacy of two carbohydrate intake strategies with similar carbohydrate content but different timing to reduce exercise-induced hypoglycemia in children with type 1 diabetes

    Institut de Recherches Cliniques de Montréal, Montreal, Canada

    Link to blog post

  • Arun Kumar Singh, M.D.

    Allan Drash Clinical Fellowship

    B. P. Koirala Institute of Health Sciences, Dharan, Nepal

    Link to blog post

  • Gianluca Tornese, M.D., Ph.D.

    Role of "taste" in metabolic regulation in T1D and mapping of mechanistically involved genes and pathways

    Institute for Maternal and Child Health “Burlo Garofolo,” Trieste, Italy

    Link to blog post

Get Involved

By donating your time or dollars, you are funding promising new scientists who share our mission of ending T1D.